Thyrocare Technologies' stock surged over 7% after the company posted a strong Q2 FY26, with revenue rising 22% YoY to ₹216.5 crore and net profit soaring 82% to ₹47.9 crore. EBITDA jumped 49% to ₹75 crore with margins at 33%. The firm also declared a ₹7 interim dividend and a 2:1 bonus issue.